This biomarker has a sensitivity of 92% and a specificity of 81% for the diagnosis of invasive candidiasis, However, the risk of false positives has been evidenced in patients receiving albumin, intravenous immunoglobulin, and systemic antimicrobials [119]. The gene discussed is ALB; the disease is Candidiasis, Invasive.